Nanotechnology as a promising strategy for alternative routes of insulin delivery

Abstract : Since its discovery, insulin has been used as highly specific and effective therapeutic protein to treat type 1 diabetes and later was associated to oral antidiabetic agents in the treatment of type 2 diabetes. Generally, insulin is administered parenterally. Although this route is successful, it still has several limitations, such as discomfort, pain, lipodystrophy at the injection sites and peripheral hyperinsulinemia, which may be the cause of side effects and some complications. Thus, alternative routes of administration have been developed, namely, those based on nanotechnologies. Nanoparticles, made of synthetic or natural materials, have been shown to successfully overcome the inherent barriers for insulin stability, degradation, and uptake across the gastrointestinal tract and other mucosal membranes. This review describes some of the many attempts made to develop alternative and more convenient routes for insulin delivery.
Type de document :
Article dans une revue
Methods in Enzymology, Elsevier, 2012, 508, pp.271-294. 〈10.1016/B978-0-12-391860-4.00014-8〉
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01491908
Contributeur : Cithefor Ul <>
Soumis le : vendredi 17 mars 2017 - 15:45:38
Dernière modification le : samedi 18 mars 2017 - 01:09:09

Identifiants

Collections

Citation

Catarina Pinto Reis, Christiane Damgé. Nanotechnology as a promising strategy for alternative routes of insulin delivery. Methods in Enzymology, Elsevier, 2012, 508, pp.271-294. 〈10.1016/B978-0-12-391860-4.00014-8〉. 〈hal-01491908〉

Partager

Métriques

Consultations de la notice

29